Showing results (411-420 of 10,183) with videos related to
Sort By:
Pageof 1,019
Molecular Pharmacology|December 1, 1995
Protein kinase C isoform delta is involved in the stimulation of the Na(+)-H+ exchanger in C6 glioma cellsC C Chen, M L WuMolecular Pharmacology|March 1, 1991
Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sitesY Itzhak, D Mash, S H Zhang, et al.Molecular Pharmacology|April 29, 2008
alpha(v)beta(3) Integrin-mediated drug resistance in human laryngeal carcinoma cells is caused by glutathione-dependent elimination of drug-induced reactive oxidative speciesAnamaria Brozovic, Dragomira Majhen, Vibor Roje, et al.Molecular Pharmacology|March 29, 2008
Phenotype of the Cyp1a1/1a2/1b1-/- triple-knockout mouseNadine Dragin, Zhanquan Shi, Rajat Madan, et al.Molecular Pharmacology|March 29, 2008
Probing the binding sites and mechanisms of action of two human ether-a-go-go-related gene channel activators, 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243)Xulin Xu, Maurizio Recanatini, Marinella Roberti, et al.Molecular Pharmacology|April 3, 2008
Refining insights into high-affinity drug binding to the human ether-à-go-go-related gene potassium channelJules C Hancox, Andrew F JamesMolecular Pharmacology|April 12, 2008
Molecular determinants for the activating/blocking actions of the 2H-1,4-benzoxazine derivatives, a class of potassium channel modulators targeting the skeletal muscle KATP channelsDomenico Tricarico, Antonietta Mele, Giulia Maria Camerino, et al.Molecular Pharmacology|May 13, 2008
Enhancing drug accumulation in Saccharomyces cerevisiae by repression of pleiotropic drug resistance genes with chimeric transcription repressorsAlexander Stepanov, Karin C Nitiss, Geoffrey Neale, et al.Molecular Pharmacology|November 1, 1991
Antipeptide antibodies localize N-(4-azido-3-[125I] iodophenethyl)spiperone binding to the carboxyl-terminal portion of the D2 dopamine receptorC David, S FuchsMolecular Pharmacology|January 1, 1991
Characterization of polyclonal antibodies to the Ah receptor prepared by immunization with a synthetic peptide haptenA Poland, E Glover, C A BradfieldPageof 1,019